Published in Immunology on May 01, 1976
Sympathetic modulation of immunity: relevance to disease. Cell Immunol (2008) 1.33
Autonomic nervous system and immune system interactions. Compr Physiol (2014) 0.92
Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology (1995) 0.86
Active E rosette formation by human lymphoblasts. Immunology (1978) 0.80
Odorants specifically modulate chemotaxis and tissue retention of CD4+ T cells via cyclic adenosine monophosphate induction. J Leukoc Biol (2016) 0.75
Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med (1972) 6.47
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev (1972) 5.10
Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol (1971) 4.09
Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc Natl Acad Sci U S A (1972) 3.65
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
The interaction of human macrophages and lymphocytes in the phytohemagglutinin-stimulated production of interferon. J Clin Invest (1971) 1.75
Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations. J Clin Invest (1975) 1.73
Stimulation of mouse B lymphocytes by trypsin. J Immunol (1974) 1.59
The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology (1975) 1.51
Immunoglobulin-like surface molecules and theta antigen during the specific and non-specific stimulation of mouse spleen cells in vitro. Clin Exp Immunol (1972) 1.38
Primary stimulation of rats and mice with hemocyanin in soluton and adsorbed on bentonite. J Immunol (1968) 1.36
The role of macrophages in the production of lymphokines by T and B lymphocytes. J Immunol (1975) 1.29
Prostaglandin E 1 as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses. Cell Immunol (1973) 1.15
The differential effect of cholera toxin on the lymphocyte stimulation induced by various mitogens. Immunology (1975) 0.93
Requirement of the macrophage or its products for the transformation of cortisol-resistant human lymphocytes by phytohemagglutinin. Immunol Commun (1974) 0.83
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum (2003) 2.51
Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ (1992) 2.18
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
Stimulation of mouse B lymphocytes by trypsin. J Immunol (1974) 1.59
The immunological significance in the guinea-pig of in vitro transformation of lymph node, spleen and peripheral blood lymphocytes. Immunology (1968) 1.52
Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Rev Rhum Engl Ed (1996) 1.47
Australia antigen and autoantibodies in chronic hepatitis. Br Med J (1970) 1.40
Immunoglobulin-like surface molecules and theta antigen during the specific and non-specific stimulation of mouse spleen cells in vitro. Clin Exp Immunol (1972) 1.38
Lymphocyte cultures in drug hypersensitivity. Lancet (1966) 1.37
Effect of hydrocortisone on the reactivity of thymus and spleen cells of mice to in vitro stimulation. Immunology (1972) 1.36
In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules. J Exp Med (1976) 1.21
Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum (1995) 1.21
Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J Clin Microbiol (2001) 1.19
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis (2004) 1.14
Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol (1989) 1.12
Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clin Rheumatol (1989) 1.06
Destructive arthropathy in generalized osteoarthritis with articular chondrocalcinosis. J Rheumatol (1975) 1.03
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Sternocostoclavicular hyperostosis: case report with a 31-year followup. Arthritis Rheum (1983) 1.01
Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis (2002) 0.99
Effect of antibodies against immunoglobulins and the theta antigen on the specific and non-specific stimulation of mouse spleen cells in vitro. Immunology (1972) 0.98
Two cases of hepatitis due to Toxoplasma gondii. Lancet (1967) 0.96
The painful heel. Comparative study in rheumatoid arthritis, ankylosing spondylitis, Reiter's syndrome, and generalized osteoarthrosis. Ann Rheum Dis (1977) 0.96
Mitogenic factors produced by lymphocyte activation: effect on T- and B-cells. J Immunol (1972) 0.95
Development of immunological memory during the primary immune response. Nature (1967) 0.95
Joint destruction and chondrocalcinosis in patients with generalised osteoarthrosis. Br Med J (1975) 0.94
The differential effect of cholera toxin on the lymphocyte stimulation induced by various mitogens. Immunology (1975) 0.93
Is chronic non-specific low back pain chronic? Definitions of a problem and problems of a definition. Br J Gen Pract (1999) 0.93
Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol (1998) 0.92
The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. Br J Rheumatol (1996) 0.91
Activation of macrophages to produce neutral proteinases by endocytosis of alpha 2-macroglobulin-trypsin complexes. J Reticuloendothel Soc (1980) 0.91
Erosive spondylopathy. Ann Rheum Dis (1980) 0.90
Health care providers should use a common language in relation to low back pain patients. Baillieres Clin Rheumatol (1998) 0.89
Synovial fluid and serum antibodies against Chlamydia in different forms of arthritis: intra-articular IgA production in Chlamydia sexually acquired reactive arthritis. Br J Rheumatol (1996) 0.89
Stimulating effect of neutral proteases on cells in vitro. Agents Actions (1976) 0.88
Culture of mouse lymphoid cells in serum-free medium. J Immunol Methods (1972) 0.88
[Treatment of lumbar sciatica with or without neurological deficit using mechanical traction. A double-blind study]. Schweiz Med Wochenschr (1988) 0.88
Trypsin increases in vitro antibody synthesis and substitutes for helper T cells. J Immunol (1976) 0.88
The role of congruence between patient and therapist in chronic low back pain patients. J Manipulative Physiol Ther (1996) 0.87
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics (1998) 0.87
Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. J Clin Microbiol (2001) 0.86
A six year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis (2002) 0.86
Levamisole and agranulocytosis. Lancet (1977) 0.85
Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis. Clin Rheumatol (2008) 0.85
A randomized, double-blind trial comparing a pulse of 1000 with 250 mg methylprednisolone in rheumatoid arthritis. Clin Rheumatol (1986) 0.84
Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) (2002) 0.83
In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules. Schweiz Med Wochenschr (1976) 0.83
The role of prior knowledge on back-pain education. J Spinal Disord (1992) 0.81
The gap between back pain patients' prior knowledge and scientific knowledge and its evolution after a back school teaching programme: a quantitative evaluation. Patient Educ Couns (1996) 0.81
Evaluation of commercially available tests for Chlamydia nucleic acid detection in synovial fluid of patients. Br J Rheumatol (1997) 0.81
Migration inhibition factor-like activity in inflammatory synovial fluids might be due to proteases. Clin Exp Immunol (1976) 0.79
Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica. J Rheumatol (1997) 0.79
OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study. J Rheumatol (1989) 0.79
Immunomodulation by alpha 2-macroglobulin and alpha 2-macroglobulin-proteinase complexes: the effect on the human T lymphocyte response. Eur J Immunol (1988) 0.79
Letter: HL-A 27 in diagnosis of rheumatic diseases. Lancet (1974) 0.79
[Destructive arthropathies associated with articular chondrocalcinosis. Clinical and metabolic study of 16 cases]. Schweiz Med Wochenschr (1976) 0.79
Human alpha 2-macroglobulin as an inhibitor of insoluble trypsin. Biochem Biophys Res Commun (1989) 0.78
Suramin stimulates B-lymphocyte proliferation in the mouse. Agents Actions (1976) 0.78
Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies? Ann Rheum Dis (2001) 0.78
Protease inhibitors reduce mitogen induced lymphocyte stimulation. Immunology (1979) 0.78
Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors. Clin Exp Rheumatol (1986) 0.78
Activation of resting T lymphocytes by cross-linked anti-CD3 (T3). Eur J Immunol (1987) 0.78
Association between human parvovirus B19 infection and arthritis. Ann Rheum Dis (1995) 0.77
Quantitative determination of antiglobulins of the IgG, IgA, and IgM class in sera of patients with rheumatoid arthritis or chronic liver disease and of healthy persons. Rev Eur Etud Clin Biol (1972) 0.77
alpha 2M-proteinase complexes are taken up by macrophages during joint inflammation. Adv Exp Med Biol (1982) 0.77
Different humoral immune response to Chlamydia trachomatis major outer membrane protein variable domains I and IV in Chlamydia-infected patients with or without reactive arthritis. Arthritis Rheum (1999) 0.76
To assess the effect of slow-acting anti-rheumatic drugs in man. Agents Actions Suppl (1979) 0.76
Diet and fatty acids: can fish substitute for fish oil? Clin Exp Rheumatol (1991) 0.76
Synovial fluid hydroxyapatite crystals: detection thresholds of two methods. Ann Rheum Dis (1989) 0.76
HLA-DR4 does not predispose to higher amounts of rheumatoid factors in healthy persons. Ann Rheum Dis (1983) 0.75
Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome. Rev Rhum Engl Ed (1996) 0.75
Neutral proteinases induce rheumatoid factor production in mouse spleen cell cultures. Clin Exp Immunol (1984) 0.75
Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Ann Rheum Dis (1982) 0.75
Pyrophosphate arthropathy in the carpal and metacarpophalangeal joints. Ann Rheum Dis (1983) 0.75
Measurements of humoral immunity during treatment with levamisole in rheumatoid arthritis--a review. J Rheumatol Suppl (1978) 0.75
[Differential diagnosis betwen Gougerot-Sjögren syndrome and sialadenosis using quantitative scintigraphy of the salivary glands]. Rev Rhum Mal Osteoartic (1977) 0.75
Efficacy and tolerance of naproxen versus pirprofen in the treatment of patients with osteoarthritis. Pharmatherapeutica (1987) 0.75
[Class II HLA antigens and rheumatoid factors in rheumatoid polyarthritis. Inverse influence of DR4 and DR7 antigens?]. Rev Rhum Mal Osteoartic (1986) 0.75
[Autoimmune mechanism in transplantation diseases in rats]. Z Rheumaforsch (1967) 0.75
[Rheumatologic problems in geriatric medicine]. Ther Umsch (1985) 0.75
[Australia- and SH-antigens in hepatitis]. Schweiz Med Wochenschr (1970) 0.75
alpha 2-Macroglobulin as an inclusion in synovial fluid monocytes. Rheumatol Int (1981) 0.75
[Australia antigen]. Schweiz Rundsch Med Prax (1971) 0.75
Secondary syphilis revealed by rheumatic complaints. J Rheumatol (1977) 0.75
[Myalgia in primary hyperparathyroidism: differential diagnosis from polymyalgia rheumatica]. Schweiz Med Wochenschr (1975) 0.75
[Immunologic diagnosis of joint diseases]. Schweiz Med Wochenschr (1982) 0.75
Protease inhibitors reduce the reverse passive Arthus reaction. Agents Actions (1978) 0.75
HLA-DR antigens and the antibody response against Epstein-Barr virus. Tissue Antigens (1984) 0.75
The effect of protease inhibitors on the immune response in mice. Agents Actions (1982) 0.75
[Isolated decalcifying algodystrophy of the hip]. Schweiz Med Wochenschr (1976) 0.75
Induction of proteolytic activity in serum by treatment with anionic detergents and organic solvents. Experientia (1983) 0.75
[The study of intra-articular infectious agents in reactive arthritis]. Ther Umsch (1989) 0.75
A subset of rheumatoid arthritis patients with a pattern of Epstein-Barr virus antibodies similar to that found in primary and secondary immunodeficiency diseases. Arthritis Rheum (1985) 0.75
[Popliteal cysts: unusual form of presentation]. Schweiz Med Wochenschr (1979) 0.75
[The significance of lymphoid cells with theta-antigen or immunoglobulin receptors during lymphocyte stimulation in vitro]. Schweiz Med Wochenschr (1972) 0.75
[Chondrocalcinosis]. Schweiz Med Wochenschr (1982) 0.75
[A propos of 2 cases of disseminated lupus erythematosus with terminal Moschcowitz's syndrome]. Schweiz Med Wochenschr (1968) 0.75
[Immunomodulation in the treatment of rheumatoid arthritis]. Ther Umsch (1986) 0.75
[Mechanism of action of gold compounds]. Wien Klin Wochenschr Suppl (1984) 0.75
[Regulatory effects of proteases in articular inflammation]. Bull Schweiz Akad Med Wiss (1979) 0.75